CRISPR Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease (NCT06925542) | CRISPR Therapeutics | 2025-03-10 |
| A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies (NCT06492304) | CRISPR Therapeutics | 2024-08-13 |
Track CRISPR Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.